Page last updated: 2024-09-05

sorafenib and gold

sorafenib has been researched along with gold in 9 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(gold)
Trials
(gold)
Recent Studies (post-2010) (gold)
6,5207305,25147,67030231,345

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Callaghan, C; Dash, S; Lee, BR; Liu, J; Maddox, M; Mandava, SH; Peralta, D; Tarr, MA1
Bardia, A; Chandrakala, L; Dhayal, M; Habeeb, MA; Khan, AA; Raju, N; Sastry, BVS; Sharmila, P; Sravani, G; Vishwakarma, SK1
Chen, X; Li, J; Xu, FJ; Yang, M; Zhang, Q; Zhao, N1
Cui, Z; Li, Q; Li, Y; Liu, L; Liu, X; Wang, J; Wang, L; Zhang, Y1
Ebrahim, HM; El-Rouby, MN; Ezz, MK; Morsy, ME; Said, MM1
Barnoin, G; Bijani, C; Cuvillier, O; Fernandez Alvarez, A; Fortin, PY; Gornitzka, H; Hemmert, C; Maddelein, ML; Qin, X; Wang, X; Zhang, C1
Dave, V; Gupta, C; Sharma, R; Sur, S1
Cai, M; Huang, W; Xing, Y; Zhu, L; Zhuo, J1
Darwish, W; El-Nagdy, M; Shafaa, M; Sukkar, F1

Other Studies

9 other study(ies) available for sorafenib and gold

ArticleYear
Combined Treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
    Journal of pharmaceutical sciences, 2016, Volume: 105, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Coumarins; Drug Compounding; Gold; Humans; Kidney Neoplasms; Lasers; Nanotubes; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Serum Albumin; Solubility; Sorafenib

2016
Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells.
    Scientific reports, 2017, 08-17, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Cell Survival; Drug Resistance, Neoplasm; Gold; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanoconjugates; Particle Size; Rats, Wistar; Sorafenib

2017
Rattle-Structured Rough Nanocapsules with in-Situ-Formed Gold Nanorod Cores for Complementary Gene/Chemo/Photothermal Therapy.
    ACS nano, 2018, 06-26, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Combined Modality Therapy; DNA; Drug Delivery Systems; Drug Screening Assays, Antitumor; Genetic Therapy; Gold; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Structure; Nanocapsules; Nanotubes; Particle Size; Phototherapy; Plasmids; Porosity; Silicon Dioxide; Sorafenib; Surface Properties

2018
Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment.
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Drug Carriers; Drug Compounding; Drug Liberation; Gold; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Low-Level Light Therapy; Metal Nanoparticles; Porosity; Silicon Dioxide; Sorafenib

2019
The Synergistic Cytotoxic Effect of Laser-Irradiated Gold Nanoparticles and Sorafenib Against the Growth of a Human Hepatocellular Carcinoma Cell Line.
    Asian Pacific journal of cancer prevention : APJCP, 2019, Nov-01, Volume: 20, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gold; Hep G2 Cells; Humans; Liver Neoplasms; Metal Nanoparticles; Sorafenib

2019
An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity.
    Angewandte Chemie (International ed. in English), 2020, 07-13, Volume: 59, Issue:29

    Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gold; Hep G2 Cells; Humans; NF-E2-Related Factor 2; Sorafenib

2020
Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy.
    Colloids and surfaces. B, Biointerfaces, 2020, Volume: 194

    Topics: Diabetes Mellitus; Diabetic Retinopathy; Drug Delivery Systems; Folic Acid; Gold; Humans; Metal Nanoparticles; Sorafenib

2020
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
    Experimental cell research, 2021, 09-01, Volume: 406, Issue:1

    Topics: Animals; Antineoplastic Agents; Capillary Permeability; Cell Movement; Cell Proliferation; Drug Carriers; ErbB Receptors; Gene Expression Regulation, Neoplastic; Gold; HCT116 Cells; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; MCF-7 Cells; Melanoma, Experimental; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myc; Skin Neoplasms; Sorafenib; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Zonula Occludens-1 Protein

2021
Polymeric Nanocarriers for Effective Synergistic Action of Sorafenib Tosylate and Gold-sensitized Gamma Radiation Against HepG2 Cells.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Antineoplastic Agents; Drug Carriers; Gamma Rays; Gold; Hep G2 Cells; Humans; Metal Nanoparticles; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sorafenib

2021